Recent article on the current sales of Gileads Hepatitis C drug Sovaldi (Sofusbuvir)

This was published just yesterday:

Gilead Profit Triples, Hepatitis C Drug Revenue Reaches $2.3B

http://www.foxbusiness.com/industries/2014/04/22/gilead-profit-triples-hepatitis-c-drug-revenue-reaches-23b/

Admiration to Henry Waxman (House of representatives) asking Gilead to explain the pricing of the drug!

Advertisements